insulin sensitizers (Evotec (Gottingen)/Boehringer Ingelheim)

N/A

Report date: 2025/06/11 20:01:15
NME

Base Information

Drug Nameinsulin sensitizers (Evotec (Gottingen)/Boehringer Ingelheim)
Drug Alias NameDG70 kinase inhibitors (DeveloGen/Boehringer Ingelheim)insulin sensitizers (DeveloGen/Boehringer Ingelheim)DG70 inhibitors (DeveloGen/Evotec)P-070DG-070 +[6] 
ClassificationSmall molecules
Mechanisms of ActionInsulin sensitizersProtein kinases inhibitors
TargetsProtein kinases
Therapy Area/IndicationsSyndromeObesityInsulin Resistance +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryGermany
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesEvotec International Gmbh
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesEvotec International GmbhBoehringer Ingelheim International GmbhEvotec SE
Active IndicationsN/A
Inactive IndicationsSyndromeObesityInsulin Resistance +[4] 

Other Information

ATC CodeN/A
Related LinksN/A